Genertec Universal Medical Group Company Limited (5UM) — Cash Flow Quality Index
Genertec Universal Medical Group Company Limited (5UM) has a Cash Flow Quality Index of -2.94x as of June 2023. Operating cash flow of €-1.67 Billion is below net income of €567.98 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore 5UM current and non-current assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Genertec Universal Medical Group Company Limited Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Genertec Universal Medical Group Company Limited across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Genertec Universal Medical Group Company tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Genertec Universal Medical Group Company Limited (2016–2025)
Year-by-year earnings quality comparison for Genertec Universal Medical Group Company Limited. For live market cap and the full company financial profile, see Genertec Universal Medical Group Company stock valuation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.61x | €5.78 Billion | €2.21 Billion | ▲ +366.7% |
| 2024 | 0.56x | €1.14 Billion | €2.03 Billion | ▼ -77.3% |
| 2023 | 2.47x | €4.99 Billion | €2.02 Billion | ▲ +127.0% |
| 2022 | 1.09x | €2.06 Billion | €1.89 Billion | ▲ +242.6% |
| 2021 | -0.76x | €-1.40 Billion | €1.84 Billion | ▼ -29.4% |
| 2020 | -0.59x | €-971.72 Million | €1.65 Billion | ▲ +48.6% |
| 2019 | -1.15x | €-1.82 Billion | €1.59 Billion | ▲ +72.9% |
| 2018 | -4.24x | €-5.73 Billion | €1.35 Billion | ▲ +4.1% |
| 2017 | -4.42x | €-5.07 Billion | €1.15 Billion | ▼ -61.7% |
| 2016 | -2.73x | €-2.38 Billion | €872.31 Million | — |